{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T03:46:16Z","timestamp":1782877576010,"version":"3.54.5"},"reference-count":34,"publisher":"China Science Publishing & Media Ltd.","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2026,6,1]]},"DOI":"10.3724\/abbs.2026104","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T07:45:08Z","timestamp":1780299908000},"update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":0,"title":["Phillyrin protects against myocardial                     ischemia\/reperfusion injury by promoting KNL1 K605 acetylation to inhibit the                     p53\/p21 pathway"],"prefix":"10.3724","author":[{"given":"Dongsheng","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangxuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqiang","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanzheng","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"CITATION1","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1159\/000518879","volume":"146","author":"Zhou M","year":"2021","unstructured":"Zhou M, Yu Y, Luo X, Wang J, Lan X, Liu P, Feng Y. Myocardial ischemia-reperfusion injury: therapeutics from a                         mitochondria-centric perspective. Cardiology, 2021, 146: 781-792.","journal-title":"Cardiology"},{"key":"CITATION2","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.tcm.2022.02.005","volume":"33","author":"Algoet M","year":"2023","unstructured":"Algoet M, Janssens S, Himmelreich U, Gsell W, Pusovnik M, Van den Eynde J, Oosterlinck W. Myocardial ischemia-reperfusion injury and the influence of                         inflammation. Trends                             Cardiovasc Med, 2023, 33: 357-366.","journal-title":"Trends                             Cardiovasc Med"},{"key":"CITATION3","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.tem.2023.10.010","volume":"35","author":"Xiang Q","year":"2024","unstructured":"Xiang Q, Yi X, Zhu XH, Wei X, Jiang DS. Regulated cell death in myocardial ischemia-reperfusion injury. Trends                             Endocrinol Metab, 2024, 35: 219-234.","journal-title":"Trends                             Endocrinol Metab"},{"key":"CITATION4","doi-asserted-by":"publisher","first-page":"e169125","DOI":"10.1172\/jci.insight.169125","volume":"9","author":"Yu W","year":"2024","unstructured":"Yu W, Kong Q, Jiang S, Li Y, Wang Z, Mao Q, Zhang X. HSPA12A maintains aerobic glycolytic homeostasis and Histone3                         lactylation in cardiomyocytes to attenuate myocardial ischemia\/reperfusion                         injury. JCI Insight, 2024, 9: e169125.","journal-title":"JCI Insight"},{"key":"CITATION5","doi-asserted-by":"publisher","first-page":"104565","DOI":"10.1016\/j.mvr.2023.104565","volume":"149","author":"Liu Y","year":"2023","unstructured":"Liu Y, Li L, Wang Z, Zhang J, Zhou Z. Myocardial ischemia-reperfusion injury; molecular mechanisms and                         prevention. Microvascular                             Res, 2023, 149: 104565.","journal-title":"Microvascular                             Res"},{"key":"CITATION6","doi-asserted-by":"publisher","first-page":"122368","DOI":"10.1016\/j.biomaterials.2023.122368","volume":"303","author":"Luo Q","year":"2023","unstructured":"Luo Q, Sun W, Li Z, Sun J, Xiao Y, Zhang J, Zhu C. Biomaterials-mediated targeted therapeutics of myocardial                         ischemia-reperfusion injury. Biomaterials, 2023, 303: 122368.","journal-title":"Biomaterials"},{"key":"CITATION7","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1056\/NEJMoa2504735","volume":"393","author":"Ibanez B","year":"2025","unstructured":"Ibanez B, Latini R, Rossello X, Dominguez-Rodriguez A, Fern\u00e1ndez-Vazquez F, Pelizzoni V, S\u00e1nchez PL. Beta-blockers after myocardial infarction without reduced                         ejection fraction. N Engl J Med, 2025, 393: 1889-1900.","journal-title":"N Engl J Med"},{"key":"CITATION8","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3892\/mmr.2021.11991","volume":"23","author":"Zheng J","year":"2021","unstructured":"Zheng J, Chen P, Zhong J, Cheng Y, Chen H, He Y, Chen C. HIF\u20111\u03b1 in myocardial ischemia\u2011reperfusion injury (Review). Mol Med Rep, 2021, 23: 352.","journal-title":"Mol Med Rep"},{"key":"CITATION9","doi-asserted-by":"publisher","first-page":"122998","DOI":"10.1016\/j.lfs.2024.122998","volume":"355","author":"Chen L","year":"2024","unstructured":"Chen L, Mao L, Xue JY, Jian YH, Deng ZW, Mazhar M, Zou Y. Myocardial ischemia-reperfusion injury: the balance mechanism                         between mitophagy and NLRP3 inflammasome. Life Sci, 2024, 355: 122998.","journal-title":"Life Sci"},{"key":"CITATION10","doi-asserted-by":"publisher","first-page":"105743","DOI":"10.1016\/j.phrs.2021.105743","volume":"170","author":"Wang K","year":"2021","unstructured":"Wang K, Li Y, Qiang T, Chen J, Wang X. Role of epigenetic regulation in myocardial ischemia\/reperfusion                         injury. Pharmacol Res, 2021, 170: 105743.","journal-title":"Pharmacol Res"},{"key":"CITATION11","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1007\/s11427-022-2257-9","volume":"66","author":"Ni L","year":"2023","unstructured":"Ni L, Lin B, Zhang Y, Hu L, Lin J, Fu F, Shen M. Histone modification landscape and the key significance of                         H3K27me3 in myocardial ischaemia\/reperfusion injury. Sci China Life                             Sci, 2023, 66: 1264-1279.","journal-title":"Sci China Life                             Sci"},{"key":"CITATION12","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41420-023-01560-5","volume":"9","author":"Cheng XL","year":"2023","unstructured":"Cheng XL, Wang K, Zhao Y, Wang K. Research progress on post-translational modification of proteins                         and cardiovascular diseases. Cell Death                             Discov, 2023, 9: 275.","journal-title":"Cell Death                             Discov"},{"key":"CITATION13","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.amjms.2023.04.034","volume":"366","author":"Yang Y","year":"2023","unstructured":"Yang Y, Ma M, Su J, Jia L, Zhang D, Lin X. Acetylation, ferroptosis, and their potential relationships:                         implications in myocardial ischemia-reperfusion injury. Am J Med Sci, 2023, 366: 176-184.","journal-title":"Am J Med Sci"},{"key":"CITATION14","doi-asserted-by":"publisher","first-page":"165728","DOI":"10.1016\/j.bbadis.2020.165728","volume":"1866","author":"Herr DJ","year":"2020","unstructured":"Herr DJ, Singh T, Dhammu T, Menick DR. Regulation of metabolism by mitochondrial enzyme acetylation in                         cardiac ischemia-reperfusion injury. Biochim                             Biophys Acta Mol Basis Dis, 2020, 1866: 165728.","journal-title":"Biochim                             Biophys Acta Mol Basis Dis"},{"key":"CITATION15","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.jare.2023.12.012","volume":"65","author":"Huang Q","year":"2024","unstructured":"Huang Q, Yao Y, Wang Y, Li J, Chen J, Wu M, Guo C. Ginsenoside Rb2 inhibits p300-mediated SF3A2 acetylation at                         lysine 10 to promote Fscn1 alternative splicing against myocardial                         ischemic\/reperfusion injury. J Adv Res, 2024, 65: 365-379.","journal-title":"J Adv Res"},{"key":"CITATION16","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.3390\/molecules27123670","volume":"27","author":"Zhou C","year":"2022","unstructured":"Zhou C, Lu M, Cheng J, Rohani ER, Hamezah HS, Han R, Tong X. Review on the pharmacological properties of phillyrin. Molecules, 2022, 27: 3670.","journal-title":"Molecules"},{"key":"CITATION17","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s12985-023-02219-4","volume":"20","author":"Zhang S","year":"2023","unstructured":"Zhang S, Sun F, Zhu J, Qi J, Wang W, Liu Z, Li W. Phillyrin ameliorates influenza a virus-induced pulmonary                         inflammation by antagonizing CXCR2 and inhibiting NLRP3 inflammasome                         activation. Virol J, 2023, 20: 262.","journal-title":"Virol J"},{"key":"CITATION18","doi-asserted-by":"publisher","first-page":"175022","DOI":"10.1016\/j.ejphar.2022.175022","volume":"927","author":"Tang K","year":"2022","unstructured":"Tang K, Zhong B, Luo Q, Liu Q, Chen X, Cao D, Li X. Phillyrin attenuates norepinephrine-induced cardiac hypertrophy                         and inflammatory response by suppressing p38\/ERK1\/2 MAPK and AKT\/NF-kappaB                         pathways. Eur J                             Pharmacol, 2022, 927: 175022.","journal-title":"Eur J                             Pharmacol"},{"key":"CITATION19","doi-asserted-by":"publisher","first-page":"112960","DOI":"10.1016\/j.intimp.2024.112960","volume":"141","author":"Ma J","year":"2024","unstructured":"Ma J, Wang Z, Sun Y, Zheng R, Tan H, Zhang H, Jin Z. Phillyrin: a potential therapeutic agent for osteoarthritis via                         modulation of NF-\u03baB and Nrf2 signaling pathways. Int                             Immunopharmacol, 2024, 141: 112960.","journal-title":"Int                             Immunopharmacol"},{"key":"CITATION20","doi-asserted-by":"publisher","first-page":"110053","DOI":"10.1016\/j.intimp.2023.110053","volume":"118","author":"Zhang X","year":"2023","unstructured":"Zhang X, Zhang HQ, Gao YK, Hao ZH, Liu JJ, Zhou GW, Liu F. Forsythoside a regulates autophagy and apoptosis through the                         AMPK\/mTOR\/ULK1 pathway and alleviates inflammatory damage in MAC-T cells. Int                             Immunopharmacol, 2023, 118: 110053.","journal-title":"Int                             Immunopharmacol"},{"key":"CITATION21","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1186\/s12964-024-01687-7","volume":"22","author":"Pan B","year":"2024","unstructured":"Pan B, Liu C, Su J, Xia C. Activation of AMPK inhibits cervical cancer growth by                         hyperacetylation of H3K9 through PCAF. Cell Commun                             Signal, 2024, 22: 306.","journal-title":"Cell Commun                             Signal"},{"key":"CITATION22","doi-asserted-by":"crossref","unstructured":"Fritz AJ, McKay KT, Greenyer HW, Pacht E, Toor RH, Ullah R, Del                         Porto JR, et al. Acetylation-mediated epigenetic                         consequences for biological control and cancer.                              Probl Cell                         Differ                          2025, 75: 25\u201369.","DOI":"10.1007\/978-3-031-91459-1_2"},{"key":"CITATION23","doi-asserted-by":"publisher","first-page":"e70141","DOI":"10.1111\/jcmm.70141","volume":"28","author":"Li J","year":"2024","unstructured":"Li J, Yushanjiang F, Fang Z, Liu W. NAT10-mediated RNA ac4C acetylation contributes to the myocardial                         infarction-induced cardiac fibrosis. J Cell Mol Medi, 2024, 28: e70141.","journal-title":"J Cell Mol Medi"},{"key":"CITATION24","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1536\/ihj.24-668","volume":"66","author":"Feng H","year":"2025","unstructured":"Feng H, Huang W, Bi X, Tang Z. Remimazolam inhibits pyroptosis after myocardial                         ischemia-reperfusion by suppressing Nat10-mediated Ac4C acetylation of Nek7. Int Heart J, 2025, 66: 475-484.","journal-title":"Int Heart J"},{"key":"CITATION25","doi-asserted-by":"publisher","first-page":"e39031","DOI":"10.1016\/j.heliyon.2024.e39031","volume":"10","author":"Xiong D","year":"2024","unstructured":"Xiong D, Wang X, Wang H, Chen X, Li H, Li Y, Zhong M. Quercetin inhibits cardiomyocyte apoptosis via                         Sirt3\/SOD2\/mitochondrial reactive oxygen species during myocardial                         ischemia-reperfusion injury. Heliyon, 2024, 10: e39031.","journal-title":"Heliyon"},{"key":"CITATION26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s10557-024-07664-z","volume":"40","author":"Fu Y","year":"2026","unstructured":"Fu Y, Wang QD, Wang DW, Li Y. Dexmedetomidine inhibits ferroptosis to alleviate                         hypoxia\/reoxygenation-induced cardiomyocyte injury by regulating the                         HDAC2\/FPN pathway. Cardiovasc                             Drugs Ther, 2026, 40: 27-38.","journal-title":"Cardiovasc                             Drugs Ther"},{"key":"CITATION27","doi-asserted-by":"publisher","first-page":"4883","DOI":"10.2147\/IJGM.S424245","volume":"16","author":"Ding Y","year":"2023","unstructured":"Ding Y, Wang K, Zhao S, Li Y, Qiu W, Zhu C, Wang Y. Role of kinetochore scaffold 1 (KNL1) in tumorigenesis and tumor                         immune microenvironment in pan-cancer: bioinformatics analyses and                         validation of expression. Int J Gen Med, 2023, 16: 4883-4906.","journal-title":"Int J Gen Med"},{"key":"CITATION28","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1161\/CIRCULATIONAHA.122.061192","volume":"148","author":"Gao F","year":"2023","unstructured":"Gao F, Liang T, Lu YW, Pu L, Fu X, Dong X, Hong T. Reduced mitochondrial protein translation promotes cardiomyocyte                         proliferation and heart regeneration. Circulation, 2023, 148: 1887-1906.","journal-title":"Circulation"},{"key":"CITATION29","doi-asserted-by":"publisher","first-page":"e2316583121","DOI":"10.1073\/pnas.2316583121","volume":"121","author":"Deng X","year":"2024","unstructured":"Deng X, He Y, Tang X, Liu X, Lee YRJ, Liu B, Lin H. A coadapted KNL1 and spindle assembly checkpoint axis                         orchestrates precise mitosis in Arabidopsis. Proc Natl Acad Sci                             USA, 2024, 121: e2316583121.","journal-title":"Proc Natl Acad Sci                             USA"},{"key":"CITATION30","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/s41418-022-00988-z","volume":"29","author":"Engeland K","year":"2022","unstructured":"Engeland K. Cell cycle regulation: P53-p21-RB signaling. Cell Death                             Differ, 2022, 29: 946-960.","journal-title":"Cell Death                             Differ"},{"key":"CITATION31","doi-asserted-by":"publisher","first-page":"155198","DOI":"10.1016\/j.phymed.2023.155198","volume":"123","author":"Li M","year":"2024","unstructured":"Li M, Yang J, Li J, Zhou Y, Li X, Ma Z, Li X. Epiberberine induced p53\/p21-dependent G2\/M cell cycle arrest and                         cell apoptosis in gastric cancer cells by activating \u03b3-aminobutyric acid                         receptor-\u03b23. Phytomedicine, 2024, 123: 155198.","journal-title":"Phytomedicine"},{"key":"CITATION32","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1158\/0008-5472.CAN-16-2098","volume":"77","author":"Kim EM","year":"2017","unstructured":"Kim EM, Jung CH, Kim J, Hwang SG, Park JK, Um HD. The p53\/p21 complex regulates cancer cell invasion and apoptosis                         by targeting Bcl-2 family proteins. Cancer Res, 2017, 77: 3092-3100.","journal-title":"Cancer Res"},{"key":"CITATION33","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2018.8382","author":"Li H","year":"2018","unstructured":"Li H, Zou T, Meng S, Peng Y, Yang J. p21 protects cardiomyocytes against ischemia-reperfusion injury                         by inhibiting oxidative stress. Mol Med Report, 2018.","journal-title":"Mol Med Report"},{"key":"CITATION34","doi-asserted-by":"publisher","first-page":"BSR20200713","DOI":"10.1042\/BSR20200713","volume":"40","author":"Yu Z","year":"2020","unstructured":"Yu Z, Ren Q, Yu S, Gao X. Sevoflurane protects cardiomyocytes against hypoxia\/reperfusion                         injury via LINC01133\/miR-30a-5p axis. Biosci Rep, 2020, 40: BSR20200713.","journal-title":"Biosci Rep"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.sciengine.com\/doi\/pdf\/D5CCE6DC233648CABDED7BCCE276F459","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2026104","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/doi\/pdf\/D5CCE6DC233648CABDED7BCCE276F459","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T02:46:54Z","timestamp":1782874014000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2026104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":34,"URL":"https:\/\/doi.org\/10.3724\/abbs.2026104","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,1]]}}}